Affiliation:
1. Department of Biochemical and Experimental Pharmacology, St. Mary's Hospital Medical School, Paddington, London, W2 1PG, UK
Abstract
Abstract
The metabolism of debrisoquine (5mg kg−1 orally) was investigated in females of 7 strains of rat. Two major metabolic pathways, those of 4- and 6- hydroxylation were found to be polymorphic. The DA strain eliminated in urine only 7–10% of the dose as 4-hydroxy-debrisoquine together with 31–55% debrisoquine while the corresponding values for the Lewis strain were 44–55% and 11–17% respectively. Accordingly, DA and Lewis rats were proposed as models for the human PM (poor metabolizer) and EM (extensive metabolizer) drug oxidation phenotypes. To further test this model, DA and Lewis rats were given phenacetin (200 mg kg−1 orally). This underwent O-de-ethylation to paracetamol (52–55%) and aromatic 2-hydroxylation (7–8%) in Lewis rats. The corresponding findings in DA rats were 35–40% O-de-ethylation and 12–13% 2-hydroxylation. It is suggested that, with respect to both debrisoquine and phenacetin, Lewis and DA inbred rat strains afford a model of oxidative drug metabolism for the human EM and PM phenotypes respectively.
Publisher
Oxford University Press (OUP)
Subject
Pharmaceutical Science,Pharmacology
Cited by
149 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献